Literature DB >> 10399780

Correlation of 99mTc-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C.

T Kira1, S Tomiguchi, M Takahashi, S Yoshimatsu, K Sagara, R Kurano.   

Abstract

99mTc-DTPA-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy was performed in 230 patients with chronic active hepatitis type C, and its quantitative indices were compared with histological findings. 99mTc-GSA findings correlated well with four indices of the histology activity index (HAI), especially with the fibrosis score. Ninety patients were given interferon treatments, and 99mTc-GSA findings were compared with the results of the treatments. We classified the effects of interferon treatment into three groups according to clinical outcome: group 1: good effect (HCV-RNA negative, n = 34), group 2: moderate effect (HCV-RNA positive, but the value of GPT was normal for six months after the end of treatment, n = 19) and group 3: no effect (n = 37). Quantitative indices of 99mTc-GSA showed significant differences between groups. Follow-up study with 99mTc-GSA scintigrams was obtained in eight patients. The results of 99mTc-GSA improved in three patients in group 1 and deteriorated in five patients in group 3. There is a possibility that 99mTc-GSA scintigraphy can be used to predict the clinical outcome of chronic active hepatitis type C after interferon treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399780

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  8 in total

1.  Fused 99m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve?

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04       Impact factor: 2.374

2.  A Novel Noninvasive Method for Predicting Liver Fibrosis by Quantifying the Estrangement of Indocyanine Green Retention Rate and Tc-99m-diethylenetriamine-penta-acetic Acid-galactosyl Human Serum Albumin Scintigraphy.

Authors:  Takehiko Hanaki; E I Uchinaka; Takuki Yagyu; Masaki Morimoto; Joji Watanabe; Kozo Miyatani; Kyoichi Kihara; Tomoyuki Matsunaga; Manabu Yamamoto; Yoji Fukumoto; Naruo Tokuyasu; Shuichi Takano; Teruhisa Sakamoto; Soichiro Honjo; Toshimichi Hasegawa; Yoshiyuki Fujiwara
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Recurrent hepatitis C after living donor liver transplantation detected by Tc-99m GSA liver scintigraphy.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Yoichiro Uchida; Morihiko Ishizaki; Takeshi Hijikawa; Takamichi Saito; Atsushi Imamura; Junko Hirohara; Yoshiko Uemura; Koichi Tanaka; Yasuo Kamiyama
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

4.  Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Yoichiro Uchida; Morihiko Ishizaki; Takamichi Saito; Kosuke Matsui; Junko Hirohara; Koichi Tanaka; Yasuo Kamiyama
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

5.  Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis.

Authors:  Masahiko Taniguchi; Atsutaka Okizaki; Kenji Watanabe; Koji Imai; Koichiro Uchida; Takahiro Einama; Noriyuki Shuke; Naoyuki Miyokawa; Hiroyuki Furukawa
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

6.  A quantitative index measured on ⁹⁹mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease.

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04-12       Impact factor: 2.374

7.  Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with (99m)Tc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice.

Authors:  Deliang Zhang; Zhide Guo; Pu Zhang; Yesen Li; Xinhui Su; Linyi You; Mengna Gao; Chang Liu; Hua Wu; Xianzhong Zhang
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

Review 8.  Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.

Authors:  Liang Wang
Journal:  Hepat Med       Date:  2010-08-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.